Skip to main content
ATOSSA THERAPEUTICS, INC. logo

ATOSSA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ATOS ISIN · US04962H5063 US Manufacturing
Open in API
Filings indexed 622 across all filing types
Latest filing 2012-06-18 Capital/Financing Update
Country US United States of America
Listing US ATOS

About ATOSSA THERAPEUTICS, INC.

https://atossatherapeutics.com/

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative medicines for areas of significant unmet medical need, with a primary focus on oncology. The company is dedicated to addressing the full continuum of breast cancer care. Its lead program is centered on (Z)-endoxifen, a proprietary and potent selective estrogen receptor modulator (SERM). Atossa is advancing (Z)-endoxifen through clinical development for multiple breast cancer indications, including metastatic disease, aiming to provide a therapeutic with a potentially improved efficacy and tolerability profile.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 4 TO FORM S-1
Capital/Financing Update Classification · 100% confidence The document is titled "Amendment No. 4 to Form S-1 Registration Statement" and is filed with the SEC. It is a registration statement under the Securities Act of 1933, related to an initial public offering (IPO) of shares. The text includes detailed information about the company, its business, financial condition, risk factors, management, and the offering itself. Form S-1 is a registration statement used by companies planning to go public to register their securities with the SEC. This type of filing is related to capital raising activities and financing. Therefore, the document is best classified as a Capital/Financing Update (CAP).
2012-06-18 English
Regulatory Filings 2012
Regulatory Filings
2012-06-13 English
Regulatory Filings 2012
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from Atossa Genetics Inc. to the U.S. Securities and Exchange Commission regarding comments on an Amendment No. 2 to a Registration Statement on Form S-1. The content includes clarifications on financial disclosures, accounting policies, revenue recognition, and other regulatory compliance matters related to the company's IPO registration statement. It references financial statements, audit reports, and accounting policies but does not itself contain the full financial statements or the registration statement itself. The document is a regulatory correspondence addressing SEC comments and amendments to a registration statement, which fits the category of Regulatory Filings (RNS). It is not an Annual Report, Audit Report, or any other specific report type but a regulatory response letter.
2012-06-11 English
FORM S-1/A
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 3 to Form S-1 Registration Statement filed with the SEC, dated June 11, 2012. It is a registration statement under the Securities Act of 1933 for Atossa Genetics Inc. The text includes detailed information about the company, its business, risk factors, management, and financial data, typical of a registration statement prospectus for an initial public offering (IPO). Form S-1 is a registration document used for securities offerings and is not a financial report like an annual or quarterly report, nor is it an earnings release or a management discussion. It is a capital markets filing related to fundraising and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement text, not just an announcement or a certification, so it is not RPA or RNS. Confidence is high due to the clear identification of the form and content.
2012-06-11 English
Regulatory Filings 2012
Regulatory Filings
2012-06-06 English
FORM S-1/A
Regulatory Filings Classification · 100% confidence The document is a Form S-1/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is related to an initial public offering (IPO) of common stock by Atossa Genetics Inc. The text includes detailed information about the company, the offering, risk factors, use of proceeds, management discussion, and financial data. This type of filing is a registration statement for securities offering, not a financial report, earnings release, or other types of corporate filings listed. The S-1/A is a regulatory filing used to register securities for public sale and is not covered by the other specific categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2012-05-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.